An important soluble regulator of the alternative pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex (COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY).
Pharmacology effect
inhibítory aktivácie komplementu
Pharmacology effect
Complement Inactivating Agents
Links
(1) - ARTICLES
(2) - BOOKS
subject heading
openseadragon
Number of the records: 1
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
